VR-assisted CBT for Adolescents With Psychosis

NCT04586868 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-05-01

No results posted yet for this study

Summary

Psychotic disorders typically emerge during late adolescence or early adulthood. Patients, who are diagnosed with a psychotic disorder before turning 18 years, are defined as early onset psychosis patients (EOP). Relative to adult patients, these patients show a worse long-term prognoses. Social impairment present a major barrier towards recovery, and thus and important issue to address in treatment. Cognitive behavioral therapy (CBT) is the recommended psychological treatment for psychotic disorders. As part of the therapy, the patient does an exposure-based training in a social environment. This type of training has several limitations for patients with psychosis. The last decade there has been a growing interest in using virtual reality (VR) to understand and treat various psychological disorders. There is a lack of research on VR-interventions for EOP patients. This study will assess the acceptability, tolerability, feasibility and clinical efficacy of a novel VR-assisted CBT interventions for adolescents with psychosis.

Conditions

  • Psychotic Disorders

Interventions

BEHAVIORAL

An intervention development study

Assessing the acceptability for a virtual reality intervention among adolescents with psychosis

BEHAVIORAL

A randomized feasibility study

Feasibility of virtual reality environment for adolescents with psychosis

BEHAVIORAL

A single-case study

The clinical efficacy of a novel VR-assisted CBT interventions for adolescents with psychosis

Sponsors & Collaborators

  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Irene Elgen, phd · Haukeland University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2024-07-31
Completion
2024-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04586868 on ClinicalTrials.gov